FFCP PHASE2:Hg19::chr4:100485183..100485202,-
From FANTOM5_SSTAR
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
| Short description: | p3@RG9MTD2 |
|---|---|
| Species: | Human (Homo sapiens) |
| DPI dataset: | Robust |
| TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
| DHS support(Yes/No): | Yes |
| Description: | CAGE_peak_3_at_RG9MTD2_5end |
| Coexpression cluster: | NA |
| Association with transcript: | 0bp_to_ENST00000394876, NM_001134665, NM_001134666, uc003huz.3, uc003hva.3_5end |
| EntrezGene: | RG9MTD2 |
| HGNC: | 28403 |
| UniProt: | Q8TBZ6 |
| Genome view: | ZENBU |
View on UCSC genome browser
Mouse over to see Genome browser image, Click image to go to Genome browser
CAGE Expression
| Sample | p3@RG9MTD2 |
|---|
0
1
2
3
4
5
6
7
8
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
| Ontology term | p-value | n |
|---|---|---|
| cancer | 1.53e-19 | 235 |
| disease of cellular proliferation | 1.00e-18 | 239 |
| hematologic cancer | 1.52e-17 | 51 |
| immune system cancer | 1.52e-17 | 51 |
| leukemia | 5.40e-14 | 39 |
| myeloid leukemia | 6.53e-12 | 31 |
| organ system cancer | 4.64e-09 | 137 |
| cell type cancer | 8.74e-07 | 143 |
Showing 1 to 8 of 8 entries
